CAMBRIDGE (CBS) — Moderna says its vaccine is 96% effective in protecting kids between 12 and 17 years old against COVID-19. That data is from a study of more than 3,2000 participants who received at least one dose of the vaccine.

The Cambridge-based biotech company also said none of the participants had severe reactions to the first or to the second shot.

READ MORE: Brush Fires Break Out Along I-280 Near Downtown San Jose

“No serious safety concerns have been identified to date,” Moderna said about the trial on teens.

READ MORE: UPDATE: Suspect Arrested After 94-Year-Old Asian Woman Stabbed In San Francisco's Tenderloin Neighborhood

Moderna said another study of the vaccine on children 6 months to 11 years old is ongoing but didn’t give further details.

MORE NEWS: Two Children Age 8 and 12 Suffer Minor Injuries in Oakland Shooting

Earlier this week Moderna, which is expanding its manufacturing plant and lab in Norwood, said a third vaccine booster dose it developed shows it works against the more contagious South African and Brazilian variants.